ADVFN Logo ADVFN

Não encontramos resultados para:
Verifique se escreveu corretamente ou tente ampliar sua busca.

Tendências Agora

Rankings

Parece que você não está logado.
Clique no botão abaixo para fazer login e ver seu histórico recente.

Hot Features

Registration Strip Icon for tools Aumente o nível de sua negociação com nossas ferramentas poderosas e insights em tempo real, tudo em um só lugar.

MRUS Merus NV

56,55
-1,10 (-1,91%)
15 Jun 2024 - Fechado
Atrasado em 15 minutos
Nome da Ação Código da Ação Bolsa de Valores Tipo de Ativo
Merus NV MRUS NASDAQ Ordinária
  Variação do Dia (p) Variação do Dia % Último Preço Hora
-1,10 -1,91% 56,55 01:00:04
Preço de Abertura Preço Mínimo Preço Máximo Fech. Hoje Fech. Anterior
57,24 55,28 58,15 56,55 57,65
mais cotações »

Notícias Recentes

Data Hora Fonte Título
03/06/202415:30GLOBEMerus’ MCLA-129 Demonstrates Promising Single-Agent..
02/06/202413:30GLOBEMerus Presents Interim Data on MCLA-145 Monotherapy and in..
29/05/202422:30GLOBEMerus Announces Pricing of Upsized Public Offering of Common..
29/05/202409:00GLOBEMerus to Participate in a Fireside Chat at the Jefferies..
28/05/202417:01GLOBEMerus N.V. Announces Proposed Public Offering of Common..
28/05/202408:00GLOBEMerus’ Petosemtamab in Combination with Pembrolizumab..
23/05/202418:00GLOBEMerus Announces Publication of an Abstract on Petosemtamab..
13/05/202409:00GLOBEPetosemtamab granted Breakthrough Therapy Designation by the..
08/05/202417:15GLOBEMerus Announces Financial Results for the First Quarter 2024..
06/05/202417:05GLOBEMerus Announces U.S. FDA Acceptance and Priority Review of..
08/04/202413:00GLOBEMerus Presents Preclinical Data Demonstrating Efficacy of..
03/04/202409:00GLOBEMerus to Participate in a Fireside Chat at the 23rd Annual..
06/03/202410:00BWGilead and Merus Announce Collaboration to Discover Novel..
05/03/202418:30GLOBEMerus Announces Publication of an Abstract for Presentation..
04/03/202410:00GLOBEMerus to Participate in a Fireside Chat at the Leerink..
28/02/202418:15GLOBEMerus Announces Financial Results for the Fourth Quarter and..
31/01/202410:00GLOBEMerus to Participate in Upcoming Investor Conferences
02/12/202322:40GLOBEMerus Presents Interim Data on MCLA-129 at ESMO Asia..
26/11/202313:05GLOBEMerus Announces Publication of Abstracts on MCLA-129 for..
02/11/202317:12GLOBEMerus Announces Financial Results for the Third Quarter 2023..
01/11/202309:00GLOBEMerus to Participate in Upcoming Investor Conferences
23/10/202308:30GLOBEMerus’ Zeno Interim Data Continues to Demonstrate Robust and..
15/10/202320:58GLOBEMerus Announces Business Update Conference Call
06/10/202310:32GLOBEMerus Announces Abstracts Accepted for Presentation at the..
31/08/202309:00GLOBEMerus to Participate in Upcoming Investor Conferences
09/08/202322:53GLOBEMerus Announces Pricing of Public Offering of Common Shares
09/08/202317:01GLOBEMerus N.V. Announces Proposed Public Offering of Common..
07/08/202317:26GLOBEMerus Announces Financial Results for the Second Quarter..
28/07/202309:00GLOBEMerus Announces Two Clinical Abstracts on Zenocutuzumab..
05/07/202317:01GLOBEZenocutuzumab (Zeno) granted second Breakthrough Therapy..
29/06/202317:30GLOBEZenocutuzumab (Zeno) granted Breakthrough Therapy..

Seu Histórico Recente